Clinical Trial Update: A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 study evaluating etrasimod for adults with moderate-to-severe atopic dermatitis has been terminated, and trial results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Etrasimod (etrasimod)

Snippet

Sponsor: Pfizer | Conditions: Atopic Dermatitis, Atopic Dermatitis, Unspecified | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2025-05-08